Harrow (HROW) Short term Debt (2011 - 2024)

Harrow (HROW) posted quarterly Short term Debt of $37.0 million for Q3 2024, up 2838.84% quarter-over-quarter from $1.3 million in Q4 2020.

Harrow (HROW) Short term Debt (2011 - 2024) Analysis & Trends

Harrow's Short term Debt history runs 8 years deep, the most recent figure standing at $37.0 million for Q3 2024.

In Q3 2024, Short term Debt changed N/A year-over-year to $37.0 million; the TTM figure through Sep 2024 stood at $37.0 million (changed N/A YoY), while the FY2020 annual figure was $1.3 million, changed N/A from the prior year.
Short term Debt for Q3 2024 stood at $37.0 million, up from $1.3 million in the prior quarter.
The five-year high for Short term Debt was $37.0 million in Q3 2024, with the low at $827000.0 in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-
2	Teva Pharmaceutical Industries	43.28 Bn	39.62 Bn	2.15 Bn
3	Zoetis	31.79 Bn	30.11 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.69 Bn	22.89 Bn	5.10 Bn
5	United Therapeutics	22.25 Bn	19.58 Bn	683.80 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn
7	Neurocrine Biosciences	15.58 Bn	15.19 Bn	935.80 Mn
8	Elanco Animal Health	11.87 Bn	11.34 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-
10	Harrow	1.58 Bn	1.49 Bn	50.36 Mn

Download Data